Pharma-bio Serv's Cash & cash equivalent grew by 5.66 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Pharma-bio Serv's Quick Ratio to 7.1, above Pharma-Bio Serv, Inc. average Quick Ratio.

Within Consulting Services industry Pharma-Bio Serv, Inc. booked the highest Quick Ratio than Pharma-bio Serv in the third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 961 to 1060.

Explain Quick Ratio?
How much Cash & cash equivalents PBSV�s has?
What are PBSV�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PBSV Quick Ratio	(Jul 31 2026) Q3	(Apr 30 2026) Q2	(Jan 31 2026) Q1	(Oct 31 2025) Q4	(Jul 31 2025) Q3
Y / Y Current Liabilities Change	-37.34 %	-37.31 %	-4.39 %	-4.39 %	-8.62 %
Y / Y Cash & cash equivalent Change	4.31 %	-19.64 %	25.05 %	25.05 %	6.7 %
Quick Ratio MRQ	7.1	6.39	4.37	4.37	4.26
PBSV's Total Ranking	# 1060	# 961	# 1007	# 909	# 1244
Seq. Current Liabilities Change	-4.82 %	-38.88 %	0 %	7.71 %	-4.77 %
Seq. Cash & cash equivalent Change	5.66 %	-10.63 %	0 %	10.46 %	-18.6 %

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Consulting Services Industry	#
Services Sector	#
Overall Market	# 0

Quick Ratio Statistics
High	Average	Low
10.45	4.52	1.68
(Oct 31 2017)		(Jan 31 2012)

Financial Statements
Pharma-bio Serv's Current Liabilities	$ 1 Millions	Visit PBSV's Balance sheet
Pharma-bio Serv's Cash & cash equivalent	$ 7 Millions	Visit PBSV's Balance sheet
Source of PBSV's Sales		Visit PBSV's Sales by Geography

Cumulative Pharma-bio Serv's Quick Ratio

PBSV's Quick Ratio for the trailling 12 Months

PBSV Quick Ratio	(Jul 31 2026) 12 Months	(Apr 30 2026) 12 Months	(Jan 31 2026) 12 Months	(Oct 31 2025) 12 Months	(Jul 31 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-20.08 %	-13.3 %	-9.22 %	-10.74 %	-12.17 %
Y / Y Cash & cash equivalent TTM Growth	6.12 %	6.72 %	6.27 %	6.42 %	6.59 %
Quick Ratio TTM	5.25	4.69	4.5	4.23	3.96
Total Ranking TTM	# 1060	# 961	# 1007	# 909	# 1244
Seq. Current Liabilities TTM Growth	-9.79 %	-9.32 %	-1.16 %	-1.15 %	-2.15 %
Seq. Cash & cash equivalent TTM Growth	1.03 %	-5.44 %	5.25 %	5.54 %	1.6 %

Quick ratio ranking by company, industry and sector >> Back to PBSV Financial Strength Comparisons >> Go to Compare PBSV Quick Ratio to its Competitors

On the trailing twelve months basis PBSV Cash & cash equivalent improved by 4.31 % in Q3 2026 year on year, while Current Liabilities decreased to $1 millions, this led to increase in in Pharma-bio Serv's Quick Ratio to 5.25, above PBSV average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Consulting Services industry PBSV achieved the highest Quick Ratio. While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents PBSV�s has?
What are PBSV�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Consulting Services Industry	#
Services Sector	#
Within the Market	# 1060

trailing twelve months Quick Ratio Statistics
High	Average	Low
10.45	4.52	1.68
(Oct 31 2017)		(Jan 31 2012)

Companies with similar Quick Ratio in the quarter ending Jul 31 2026, within Consulting Services Industry	Quick Ratio	Jul 31 2026 MRQ Cash & cash equivalent	Jul 31 2026 MRQ Current Liabilities
Pharma-Bio Serv, Inc.	7.10	$ 7.059 Millions	$ 0.995 Millions
Castellum Inc	3.16	$ 16.865 Millions	$ 5.334 Millions
Mastech Digital Inc	2.11	$ 35.603 Millions	$ 16.893 Millions

Date modified: 2026-09-15T11:59:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.